PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 14555704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triptolide inhibits the growth and metastasis of solid tumors.

  2003cited by this paper
• Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status

  2002cited by this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract

  2002cited by this paper
• Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.

  2001cited by this paper
• The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression

  2001cited by this paper
• Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook F

  2001cited by this paper
• Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells

  2001cited by this paper
• Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

  2001cited by this paper
• hADA3 is required for p53 activity

  2001cited by this paper
• Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis

  2001cited by this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.

  2000cited by this paper
• PREVENTION OF GRAFT-VERSUS-HOST DISEASE BY A NOVEL IMMUNOSUPPRESSANT, PG490–88, THROUGH INHIBITION OF ALLOREACTIVE T CELL EXPANSION

  2000cited by this paper
• The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.

  2000cited by this paper
• Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor.

  2000cited by this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.

  2000cited by this paper
• Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptors, as a Novel Transcriptional Corepressor Molecule of Activating Protein-1, Nuclear Factor-κB, and Serum Response Factor*

  2000cited by this paper
• PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells*

  1999cited by this paper
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

  1999cited by this paper
• Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.

  1999cited by this paper
• Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation*

  1999cited by this paper
• Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters.

  1998cited by this paper
• Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii.

  1997cited by this paper
• Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice.

  1997cited by this paper
• Immunosuppression of triptolide and its effect on skin allograft survival.

  1992cited by this paper
• Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii.

  1972cited by this paper

• Triptolide derivative STP1 ameliorates murine systemic lupus erythematosus via targeting Fyn kinase.

  2026cites this paper
• High efficacy and biocompatibility: Application and biological evaluation of LA67 liposome in colon cancer therapy.

  2026cites this paper
• Pro-drug approaches to overcome poor solubility and toxicity of triptolide

  2025cites this paper
• From immunosuppression to immune reprogramming: is triptolide a potential “immune reset” agent in autoimmune diseases?

  2025cites this paper
• Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers.

  2024cites this paper
• Phytochemicals for Cancer Treatment: An Update on Plant-Derived Anti-Cancer Compounds and their Mechanisms of Action.

  2024cites this paper
• Natural-source Payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.

  2024cites this paper
• Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice

  2023cites this paper
• The roles of TPL in hematological malignancies

  2023cites this paper
• Synergism and attenuation of triptolide through prodrug engineering combined with liposomal scaffold strategy to enhance inhibition in pancreatic cancer.

  2023cites this paper
• Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives

  2021cites this paper
• Psilostachyins as trypanocidal compounds: Bioguided fractionation of Ambrosia tenuifolia chemically modified extract.

  2021cites this paper
• Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity

  2021cites this paper
• Therapeutic potential of medicinal plants: A review

  2020cites this paper
• Medicinal Based Plants: A Call to Nature

  2020cites this paper
• Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67

  2020cites this paper
• Triptolide and Its Derivatives as Cancer Therapies.

  2019cites this paper
• Highlights of Natural Products in Prostate Cancer Drug Discovery

  2019cites this paper
• Triptolide: Medicinal chemistry, chemical biology and clinical progress.

  2019cites this paper
• Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents.

  2019cites this paper
• Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug.

  2019cites this paper
• NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation.

  2018cites this paper
• 21 Highlights of Natural Products in Prostate Cancer Drug Discovery

  2018cites this paper
• Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells

  2018cites this paper
• The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation

  2018influential citation
• TRIPTOLIDE COMPOUNDS FROM TRIPTERYGIUM WILFORDII

  2017cites this paper
• Natural Products Targeting Clinically Relevant Enzymes of Eicosanoid Biosynthesis Implicated in Inflammation and Cancer

  2017cites this paper
• Review on Phytochemicals with their biological roles

  2017cites this paper
• Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells

  2017cites this paper
• Critical Role of Hepatic Cyp450s in the Testis-Specific Toxicity of (5R)-5-Hydroxytriptolide in C57BL/6 Mice

  2017cites this paper
• The efficacy of plant extract and bioactive compounds approaches in the treatment of pulmonary fibrosis: A systematic review.

  2017influential citation
• New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds

  2017cites this paper
• TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor‐alpha in cancer cells

  2017cites this paper
• Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review

  2016cites this paper
• Targeting arachidonic acid pathway by natural products for cancer prevention and therapy.

  2016cites this paper
• Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.

  2016cites this paper
• IAP Family of Proteins as Therapeutic Targets for Acute Myeloid Leukemia

  2015cites this paper
• THE ROLE OF NATURAL PRODUCTS IN DRUG DISCOVERY AND DEVELOPMENT

  2015cites this paper
• Activators and Inhibitors of ADAM‐10 for Management of Cancer and Alzheimer's Disease

  2015cites this paper
• Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts

  2015cites this paper
• Triptolide Attenuates Myocardial Ischemia/Reperfusion Injuries in Rats by Inducing the Activation of Nrf2/HO-1 Defense Pathway

  2015cites this paper
• Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model.

  2015cites this paper
• Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F

  2015cites this paper
• Application of Traditional Chinese Medicine in Cancer Treatment

  2015cites this paper
• Triptolide: Novel Anticancer Agent for Chemoresistant Cancer Cells that are Caspase-3 Deficient

  2014cites this paper
• The Water-Soluble Triptolide Derivative PG490-88 Protects against Cisplatin-Induced Acute Kidney Injury

  2014influential citation
• Conjugating glucosamine to triptolide to enhance its protective effect against renal ischemia-reperfusion injury and reduce its toxicity

  2014cites this paper
• The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone.

  2014cites this paper
• Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation

  2014cites this paper
• Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.

  2014cites this paper
• Design, Synthesis and Structure–Activity Relationships Studies on the D Ring of the Natural Product Triptolide

  2014cites this paper
• Design, synthesis and anticancer activity evaluation of novel C14 heterocycle substituted epi-triptolide.

  2014cites this paper
• Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas

  2014cites this paper
• Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase

  2013cites this paper
• Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis.

  2013cites this paper
• 雷公藤内酯醇与非小细胞肺癌研究进展

  2013cites this paper
• Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120–180

  2013cites this paper
• Antagonist Effect of Triptolide on AKT Activation by Truncated Retinoid X Receptor-alpha

  2012cites this paper
• Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.

  2012cites this paper
• Triptolide inhibits proliferation and invasion of malignant glioma cells

  2012cites this paper
• Tripterygium wilfordii bioactive compounds as anticancer and anti‐inflammatory agents

  2012cites this paper
• DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

  2012influential citation
• MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML

  2012cites this paper
• Pancreas Cancer Meets the Thunder God

  2012cites this paper
• Mechanism of Action of the Anti-cancer Agent, Triptolide

  2012cites this paper
• Combination of Natural Drugs: An Emerging Trend in Cancer Chemotherapy

  2012cites this paper
• Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.

  2012cites this paper
• Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.

  2012cites this paper
• Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer

  2012cites this paper
• A Historical Overview of Natural Products in Drug Discovery

  2012cites this paper
• Triptolide (TPL) Inhibits Global Transcription by Inducing Proteasome-Dependent Degradation of RNA Polymerase II (Pol II)

  2011cites this paper
• Triptolide-induced cell cycle arrest and apoptosis in human renal cell carcinoma cells.

  2011cites this paper
• Triptolide and its expanding multiple pharmacological functions.

  2011cites this paper
• Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells.

  2011cites this paper
• Highlights of natural compounds in prostate cancer drug discovery

  2011cites this paper
• The effects of triptolide on airway remodelling and transforming growth factor‐β1/Smad signalling pathway in ovalbumin‐sensitized mice

  2011cites this paper
• First total synthesis of tripdiolide

  2011cites this paper
• Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model

  2011cites this paper
• XPB, a subunit of TFIIH, is a target of the natural product triptolide.

  2011cites this paper
• Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.

  2011cites this paper
• Complexation of triptolide and its succinate derivative with cyclodextrins: affinity capillary electrophoresis, isothermal titration calorimetry and 1H NMR studies.

  2011cites this paper
• In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells.

  2011cites this paper
• Anticancer antioxidant regulatory functions of phytochemicals.

  2011cites this paper
• Herbal Medicines and Animal Models of Gastrointestinal Diseases

  2010cites this paper
• Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.

  2010cites this paper
• Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.

  2010cites this paper
• Triptolide simultaneously induces reactive oxygen species, inhibits NF-kappaB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines.

  2010cites this paper
• The continuing search for antitumor agents from higher plants.

  2010cites this paper
• MAPKs Are Not Involved in Triptolide-Induced Cell Growth Inhibition and Apoptosis in Prostate Cancer Cell Lines with Different p53 Status

  2010cites this paper
• Triptolide inhibits Jak2 transcription and induces apoptosis in human myeloproliferative disorder cells bearing Jak2V617F through caspase-3-mediated cleavage of Mcl-1.

  2010cites this paper
• Terrestrial Plants as a Source of Novel Pharmaceutical Agents

  2010cites this paper
• Triptolide functions as a potent angiogenesis inhibitor

  2010cites this paper
• A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-κB Pathway

  2009cites this paper
• Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.

  2009cites this paper
• Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation

  2009cites this paper
• Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells

  2009cites this paper
• Triptolide abrogates oncogene FIP1L1‐PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome

  2009cites this paper
• Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells

  2009cites this paper
• Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

  2009cites this paper
• A Small Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-regulation of NF-κB Pathway

  2009cites this paper